Biology and management of AIDS-associated non-Hodgkin's lymphoma.
The treatment of HIV-related lymphomas is evolving in the era of HAART. Standard-dose chemotherapy and dose-intensive therapies appear to be feasible. Whether outcomes are improved with combination chemotherapy and HAART remains unclear. Efforts aimed at developing pathogenic-based therapies will continue as the mechanisms of HIV lymphomagenesis are elucidated.
Gates
Amy E
AE
Positive Health Program, San Francisco General Hospital, University of California at San Francisco, 995 Potrero Avenue, Building 80, Ward 84, San Francisco, CA 94110, USA. agates@php.ucsf.edu
Kaplan
Lawrence D
LD
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D019468:Disease Management; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000145:classification / Q000188:drug therapy* / Q000209:etiology*; D008228:Lymphoma, Non-Hodgkin; D016879:Salvage Therapy